Breaking News, Collaborations & Alliances

Schrödinger Adopts the Sapio Platform to Enhance In Silico Drug Discovery

By deploying Sapio’s unified informatics platform, Schrödinger is transforming its wet lab operations, integrating data, and streamlining workflows.

Author Image

By: Charlie Sternberg

Associate Editor

Schrödinger, a global leader in computational chemistry, has adopted the Sapio Sciences Platform to improve data management, enhance lab efficiency, and accelerate the discovery of novel molecules at its internal wet lab. Dr. Rajesh Kumar, Senior Director of Drug Discovery at Schrödinger, commented: “Sapio’s solution has allowed us to digitize critical lab functions, improve efficiency, and ensure seamless sample traceability across our research and discovery processes. By unifying data and a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters